The Parkinson’s community often asks, “What new treatments are in the pipeline?” The good news is the pipeline is bursting with new opportunities. That includes different approaches to treat the full spectrum of Parkinson’s, from early diagnosis to advancing disease. In this audio from our Third Thursdays Webinar, our expert panel of scientists from The Michael J. Fox Foundation (MJFF) share some of these approaches and impactful research updates from 2022.
If you’d rather listen on the go, subscribe to our Michael J. Fox Foundation Parkinson's Podcast on iTunes or through any podcast app on your smartphone or tablet. If you enjoyed what you heard, share it with a friend or leave a review on iTunes. It helps listeners like you find and support our mission.
In this podcast, moderator Brian Fiske, PhD, co-chief scientific officer at MJFF, leads a discussion with expert panelists:
- Jamie Eberling, PhD, senior vice president, research resources, MJFF
- Katie Kopil, PhD, senior vice president, clinical research, MJFF
- Shalini Padmanabhan, PhD, vice president, research programs, MJFF
Want to take a deeper dive into research progress the panelists spoke about? Read our year in review publication.
To view the slides and other resources from the webinar, watch on demand anytime.
Our landmark Parkinson’s Progression Markers Initiative (PPMI) is enrolling volunteers with and without Parkinson’s disease. Learn more at michaeljfox.org/podcast-ppmi.